Cancer and the kidney.
This article provides a summary of renal cancers that can affect adolescent patients. It encompasses both isolated and syndrome-associated cancers and the various renal complications associated with cancer therapy. Prompt recognition and appropriate referral and management, along with periodic long-term follow-up, will enhance both the survival and quality of life of young people afflicted with these serious diseases.
Keaney
Christina M
CM
Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA.
Springate
James E
JE
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000401:mortality; D015897:Comorbidity; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects; D052177:Kidney Diseases, Cystic / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications; D007679:Kidney Medulla / Q000473:pathology; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy; D008223:Lymphoma / Q000175:diagnosis; D009392:Nephrectomy; D011379:Prognosis; D014402:Tuberous Sclerosis / Q000453:epidemiology / Q000473:pathology; D015275:Tumor Lysis Syndrome / Q000503:physiopathology / Q000628:therapy; D009396:Wilms Tumor / Q000235:genetics / Q000401:mortality / Q000628:therapy; D006623:von Hippel-Lindau Disease / Q000175:diagnosis / Q000473:pathology
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D007069:Ifosfamide